Friday, February 24th, 2023
| 6:00 – 7:00 PM | Welcome Reception | South Ballroom |
| 7:00 – 9:30 PM | Welcome Dinner with Keynote Speaker- Climate Change: Our Role as Health Care Providers | Dr. Maura Brown- South Ballroom |
Saturday, February 25th, 2023
| 7:00 – 7:50 AM | Breakfast | Kerrisdale Ballroom |
| 7:55 – 8:00 AM | BCGU Welcome | Dr. Krista Noonan- GUTG Systemic Chair- South Ballroom |
Prostate Session 1: Localized PC – Session Chairs: Dr. Iain McAuley and Dr. Charmaine Kim Sing
All Sessions include 25% of Time for Question Periods and Audience Participation
| 8:00 – 8:20 AM | Optimal Workup of Local Disease: Transperineal Biopsy, PSMA PET | Dr. Miles Mannas |
| 8:20 – 8:40 AM | Localized High Risk Disease: Optimal Dose Escalation of RT | Dr. David Kim |
| 8:40 – 9:00 AM | High Risk Localized PC: Is the Addition of ARAT to ADT+RT Now Standard? | Dr. Mira Keyes |
| 9:00 – 9:30 AM | Debate: Has PSMA PET Significantly Helped with Patient and Treatment Selection in the Salvage Setting Post Prostatectomy? | NO PSMA PET: Dr. Michael Peacock |
| YES PSMA PET: Dr. Justin Lee | ||
| 9:30 – 9:50 AM | Panel Discussion and Cases: High Risk Pathologies : Management of Local and Metastatic Disease (Intraductal /Cribriform) | Panelists: Dr. Jeff McCracken, Dr. Gang Wang, Dr. Ryan Urban & Dr. Cal Andreou |
| 9:50 – 10:10 AM | Genetic Testing: When, Whom, How, Why? | Dr. Alex Wyatt |
| 10:10 – 10:30 AM | PMSA PET Positive versus Conventional Imaging Positive: Implications | Dr. Scott Tyldesley |
| 10:30 – 10:50 AM | Health Break & Networking |
RCC Session – Session Chairs: Dr. Andrew Attwell and Dr. Vu Truong
All Sessions include 25% of Time for Question Periods and Audience Participation
| 10:50 – 11:10 AM | Panel Discussion and Cases: Management of Growing Renal Masses: SBRT vs Surgery vs RFA | Chair: Dr. John Kinahan Panelists: Dr. Mike Eng, Dr. David Liu & Dr. Howard Pai |
| 11:10 – 11:30 AM | Debate: Adjuvant Immunotherapy: To Give or Not To Give | PRO: Dr. Jesse Shustik |
| CON: Dr. Lyly Le | ||
| 11:30 – 11:50 AM | Cytoreductive Nephrectomy: Upfront or Delayed (and When to Refer Back) | Dr. Brian Yang |
| 11:50 – 12:10 PM | First-line mRCC: Triplet Versus Doublet ? | Dr. Joanna Vergidis |
| 12:10 – 12:30 PM | Oligometastases / Oligoprogression: Role of Local Treatment Intensification | Dr. Soha Atallah |
| 12:30 – 12:45 PM | VHL Disease: Novel Management Options | Dr. Maryam Soleimani |
| 12:45 – 1:45 PM | LUNCH / Networking / Exhibition |
Testis Cancer Session – Session Chairs: Dr. Param Bains and Dr. Ian Wright
All Sessions include 25% of Time for Question Periods and Audience Participation
| 1:45 – 2:05 PM | miRNA 371 – A New Biomarker ? | Dr. Lucia Nappi |
| 2:05 – 2:25 PM | IGCCCG Poor Risk Choriocarcinoma – An Oncologic Emergency. | Dr. David Telio |
| 2:25 – 2:45 PM | Surgery for Early Stage Metastatic Testis Cancer – Ready for Prime Time ? | Dr. Matthew Ho |
| 2:45 – 2:50 PM | Closing Remarks for Day 1 | Dr. Chris Hoag – BCUS Chair |
| 7:00 PM | Dinner/Reception | Paradox Hotel- Kerrisdale Room |
Sunday, February 26th, 2023
| 7:00 – 8:00 AM | Breakfast | Centre Foyer/South Ballroom |
|
8:00 – 8:05 AM
|
Welcome -Dr. Jack Zheng GUTG RT Chair | Dr. Jack Zheng – GURG RT Chair – South Ballroom |
Bladder Cancer Session – Session Chairs: Dr. Ardashes Avanessian and Dr. Alym Abdulla
All Sessions include 25% of Time for Question Periods and Audience Participation
| 8:05 – 8:25 AM | Evolving Medical Management of Non-muscle Invasive UC | Dr. Michael Metcalfe |
| 8:25 – 8:45 AM | Bladder Preservation and Trimodal Therapy: Indications and Approaches | Dr. Nathan Wong |
| 8:45 – 9:05 AM | Neoadjuvant Chemotherapy: ddMVAC vs cis/gem | Dr. JM Lavoie |
| 9:05 – 9:25 AM | Debate: ctDNA Should Be Used to Guide Adjuvant IO After Radical Cystectomy | PRO: Dr. Corinne Maurice Dror |
| CON: Dr. Richard Gagnon | ||
| 9:25 – 9:45 AM | Biomarker Directed Therapies: HER-2, FGFR, ADCs | Dr. Daniel Khalaf |
| 9:45 – 10:05 AM | Treatment Sequencing in Metastatic Disease | Dr. Bernie Eigl |
| 10:05 – 10:25 AM | Panel Discussion and Cases: Upper Tract UC Management: | Panelists: Drs. Dinesh Samarasekera, Stacy Miller, Michael Humphreys & Richard Gagnon |
| 10:25 – 10:50 AM | Health Break / Networking / Exhibition / Check-out |
Prostate Cancer Session 2: mCRPC – Session Chairs: Dr. Dylan Narinesingh
All Sessions include 25% of Time for Question Periods and Audience Participation
| 10:50 – 11:10 AM | mCSPC: Doublet or Triplets | Dr. Simon Yu |
| 11:10 – 11:30 AM | PARP Inhibitors: Selected or Unselected Patient Population? | Dr. Sunil Parimi |
| 11:30 – 11:50 AM | Treatment Sequencing in the Era of Lutetium | Dr. Kim Chi |
| 11:50 – 12:10 PM | Management of Oligometastatic Disease: Metastasis Directed Therapy? ADT? RT to Primary? | Dr. Jim Ddamba |
| 12:10 – 12:15 PM | BCGU Conference Closing Remarks | Dr. Christian Kollmannsberger |